A potential political conflict over both the French health insurance budget and a proposed regime of patient charges has erupted following a council meeting of the national sickness insurance funds (CNAM). The problems stem from the higher-than-forecast 2007 deficit of 6.4 billion euros ($8.76 billion) in the social security system that is responsible for the reimbursement of health care spending, including prescription drugs.
Frederic van Roekeghem, the CNAM's Director, presented his plans to the council meeting for spending cuts of about 3.8 billion euros for 2008. Representatives of both employer federations and labor unions "took note" of the proposals, effectively distancing themselves from them.
In response to the continued difficulties of the CNAM and the ever increasing fiscal measures aimed at subsidizing it, Contribuables Associes, a taxpayers' group, welcomed some measures, such as removing aspirin and paracetamol from the list of reimbursable drugs, as well the end of subsidized thalassotherapy cures, which have been notoriously exploited by some people as tax-funded seaside holidays.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze